Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4)

Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A. Rocca

doi:10.1038/s41572-018-0050-3

Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4)

Massimo Filippi, Amit Bar-Or, Fredrik Piehl, Paolo Preziosa, Alessandra Solari, Sandra Vukusic, Maria A. Rocca

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the originally published version of this article, in Table 4, Ocrelizumab was incorrectly referred to as an anti-CD25 antibody. This has been corrected in the HTML and PDF versions of the article to an anti-CD20 antibody.

Original language	English
Article number	49
Journal	Nature Reviews Disease Primers
Volume	4
Issue number	1
DOIs	https://doi.org/10.1038/s41572-018-0050-3
Publication status	Published - Dec 1 2018

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1038/s41572-018-0050-3

Cite this

Erratum to : Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4). / Filippi, Massimo; Bar-Or, Amit; Piehl, Fredrik; Preziosa, Paolo ; Solari, Alessandra; Vukusic, Sandra; Rocca, Maria A.

In: Nature Reviews Disease Primers, Vol. 4, No. 1, 49, 01.12.2018.

Research output: Contribution to journal › Comment/debate › peer-review

@article{f74d6aa617254001b97fe232235821d0,

title = "Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4)",

abstract = "In the originally published version of this article, in Table 4, Ocrelizumab was incorrectly referred to as an anti-CD25 antibody. This has been corrected in the HTML and PDF versions of the article to an anti-CD20 antibody.",

author = "Massimo Filippi and Amit Bar-Or and Fredrik Piehl and Paolo Preziosa and Alessandra Solari and Sandra Vukusic and Rocca, {Maria A.}",

year = "2018",

month = dec,

day = "1",

doi = "10.1038/s41572-018-0050-3",

language = "English",

volume = "4",

journal = "Nature Reviews Disease Primers",

issn = "2056-676X",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Erratum to

T2 - Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4)

AU - Filippi, Massimo

AU - Bar-Or, Amit

AU - Piehl, Fredrik

AU - Preziosa, Paolo

AU - Solari, Alessandra

AU - Vukusic, Sandra

AU - Rocca, Maria A.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - In the originally published version of this article, in Table 4, Ocrelizumab was incorrectly referred to as an anti-CD25 antibody. This has been corrected in the HTML and PDF versions of the article to an anti-CD20 antibody.

AB - In the originally published version of this article, in Table 4, Ocrelizumab was incorrectly referred to as an anti-CD25 antibody. This has been corrected in the HTML and PDF versions of the article to an anti-CD20 antibody.

UR - http://www.scopus.com/inward/record.url?scp=85057121878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057121878&partnerID=8YFLogxK

U2 - 10.1038/s41572-018-0050-3

DO - 10.1038/s41572-018-0050-3

M3 - Comment/debate

C2 - 30467372

AN - SCOPUS:85057121878

VL - 4

JO - Nature Reviews Disease Primers

JF - Nature Reviews Disease Primers

SN - 2056-676X

IS - 1

M1 - 49

ER -

Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this